Financhill
Back

NovoCure Stock Predictions

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 40.2% based on the past 9 years of stock performance.
  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $30.97. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 40.2% based on the past 9 years of stock performance.

NovoCure Stock Rating

Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
34.13
52-Week Low:
11.70

Prediction Charts

Market Cap:
3.4B
Price in USD:
30.97
Volume:
312.4K
Beta:
1.13

Technical Analysis

SMA50:
21.62
SMA100:
19.47
SMA200:
18.41
52-Wk Change:
132.86%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 30.97 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 29.04 26.60 29.32 26.50
Dec-6 27.55 27.96 28.38 26.45
Dec-9 28.00 28.65 28.82 27.56
Dec-10 28.52 29.72 29.96 28.00
Dec-11 30.15 31.13 31.67 29.29
Dec-12 31.14 30.06 31.51 29.75
Dec-13 31.22 33.41 34.00 30.56
Dec-16 33.28 31.75 33.82 31.60
Dec-17 31.76 32.10 33.00 31.45
Dec-18 31.99 31.53 34.13 30.58
Dec-19 31.72 30.40 31.92 29.79
Dec-20 30.33 30.83 31.52 30.33
Dec-23 30.84 30.49 31.03 29.85
Dec-24 30.49 30.97 31.01 29.81

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.